RA
ARAV

Royce & Associates’s Aravive, Inc. Common Stock ARAV Stock Holding History

Royce & Associates’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,599
Closed -$438K – 1112
2016
Q2 		$438K Hold
6,599
– – ﹤0.01% 1001
2016
Q1 		$318K Sell
6,599
-2,166
-25% -$115K ﹤0.01% 1022
2015
Q4 		$652K Sell
8,765
-1,667
-16% -$112K ﹤0.01% 988
2015
Q3 		$722K Buy
+10,432
New +$979K ﹤0.01% 1004
2014
Q3 		– Sell
-17
Closed -$3K – 1436
2014
Q2 		$3K Buy
+17
New +$2.93K ﹤0.01% 1421

Other funds holding ARAV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Royce & Associates's ARAV Position: Q3 2016 in Review

Royce & Associates sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2016, closing a stake of 6,599 shares — an estimated $438K sold.

Royce & Associates first reported a position in ARAV in Q2 2014 and held it in 5 quarters. The position peaked at $722K in Q3 2015. 74 funds tracked by Wall St. Rank hold ARAV as of Q3 2016.

  • Royce & Associates reported no remaining Aravive, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Royce & Associates sold 6,599 Aravive, Inc. Common Stock shares in Q3 2016, an estimated $438K.
  • Royce & Associates first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 5 quarters.
  • Royce & Associates's Aravive, Inc. Common Stock position peaked at $722K in Q3 2015.
  • 74 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2016.

Based on Royce & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.